Literature DB >> 6873014

Factors that promote the development of human breast cancer.

D B Thomas.   

Abstract

Epidemiologic and endocrinologic studies of breast cancer etiology are reviewed in the context of the Moolgavkar two-stage model for mammary carcinogenesis. Promoters are hypothesized to enhance the growth of stem and intermediate cells, and initiators are assumed to cause stem and intermediate cells to give rise to intermediate and tumor cells, respectively. Although all epidemiologic features of breast cancer can be explained in terms of the cellular events supposed by the model, the specific causes of breast cancer are largely unknown. Aberrations in endogenous steroid sex hormones most probably act as promoters, although their exact nature and etiology are unclear. Ionizing radiation is the only known initiator. The two-stage model implies that others exist and that they are responsible for both the international variation in risk of breast cancer, and its familial aggregation. Results of endocrinologic studies suggest either that aberrations in endogenous sex hormones serve as such initiators or are correlated with them, or that familial and international variations in risk are mediated by promoters.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873014      PMCID: PMC1569207          DOI: 10.1289/ehp.8350209

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  74 in total

1.  Urinary and plasma androgens in benign breast disease. Possible relation to breast cancer.

Authors:  M J Brennan; D Y Wang; J L Hayward; R D Bulbrook; N Deshpande
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

2.  Relation between urinary androgen and corticoid excretion and subsequent breast cancer.

Authors:  R D Bulbrook; J L Hayward; C C Spicer
Journal:  Lancet       Date:  1971-08-21       Impact factor: 79.321

3.  Gut bacteria and aetiology of cancer of the breast.

Authors:  M J Hill; P Goddard; R E Williams
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

Review 4.  Endocrine influences on human mammary cancer formation. A critique.

Authors:  H M Lemon
Journal:  Cancer       Date:  1969-04       Impact factor: 6.860

5.  Breast cancer after exposure to the atomic bombings of Hiroshima and Nagasaki.

Authors:  C K Wanebo; K G Johnson; K Sato; T W Thorslund
Journal:  N Engl J Med       Date:  1968-09-26       Impact factor: 91.245

6.  Plasma prolactin in breast cancer.

Authors:  A R Boyns; E N Cole; K Griffiths; M M Roberts; R Buchan; R G Wilson; A P Forrest
Journal:  Eur J Cancer       Date:  1973-02       Impact factor: 9.162

Review 7.  Dietary fat and mammary cancer.

Authors:  K K Carroll; E B Gammal; E R Plunkett
Journal:  Can Med Assoc J       Date:  1968-03-23       Impact factor: 8.262

8.  Breast neoplasms in women treated with x rays for acute postpartum mastitis. A pilot study.

Authors:  F A Mettler; L H Hempelmann; A M Dutton; J W Pifer; E T Toyooka; W R Ames
Journal:  J Natl Cancer Inst       Date:  1969-10       Impact factor: 13.506

9.  Breast cancer following multiple fluoroscopies during artificial pneumothorax treatment of pulmonary tuberculosis.

Authors:  J A Myrden; J E Hiltz
Journal:  Can Med Assoc J       Date:  1969-06-14       Impact factor: 8.262

10.  Metabolic clearance and blood production rates of estrogens in postmenopausal women.

Authors:  C Longcope
Journal:  Am J Obstet Gynecol       Date:  1971-11       Impact factor: 8.661

View more
  2 in total

1.  Oestrogen receptor activity in intraduct and invasive breast carcinomas.

Authors:  R A Hawkins; A L Tesdale; W A Ferguson; J J Going
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

Review 2.  Lactation and breast cancer risk.

Authors:  P A Newcomb
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-07       Impact factor: 2.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.